Factors associated with uptake of subdermal contraceptive implants in a young Kenyan population.

نویسندگان

  • David Hubacher
  • Alice Olawo
  • Carolyne Manduku
  • James Kiarie
چکیده

BACKGROUND Subdermal contraceptive implants may be a reasonable option for young women in sub-Saharan Africa; little is known about factors associated with method uptake in this subpopulation. STUDY DESIGN Four hundred women aged 18-24 years who sought short-acting hormonal contraception were offered an opportunity to use an implant instead. Cross-tabulations and logistic regression analysis were used to examine participant characteristics and other factors associated with choosing an implant. RESULTS Twenty-four percent of participants chose the implant. Participants with greater than 4 years of contraceptive need were over three times more likely to choose an implant [odds ratio (OR), 3.4; 95% confidence interval (CI), 1.6-6.9]. Women with health concerns over short-acting hormonal methods (OR, 2.2; 95% CI, 1.3-3.6) and those who expressed some difficulty returning to a clinic (OR, 1.9; 95% CI, 1.1-3.1) were about twice as likely to choose an implant. Product attributes such as long-acting protection and convenience were cited reasons for choosing an implant. CONCLUSIONS The implant appears to be an attractive option for a fairly large proportion of young women in Kenya. Within this age group of implant users, homogeneity of demographic characteristics relative to short-acting users suggests that the product has broad appeal.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Preventing unintended pregnancy among young women in Kenya: prospective cohort study to offer contraceptive implants.

BACKGROUND Subdermal contraceptive implants have low discontinuation rates but are underused among young women in Africa. This study aimed to isolate the role initial contraceptive method has on preventing unintended pregnancy. STUDY DESIGN We recruited 399 Kenyan women aged 18-24 years into a prospective cohort study if they wanted short-acting hormonal methods (injectable or oral contracept...

متن کامل

Factors influencing uptake of contraceptive implants in the immediate postpartum period among HIV infected and uninfected women at two Kenyan District Hospitals

BACKGROUND Family planning is a cost effective strategy for prevention of mother to child transmission of HIV and reduction of maternal/infant morbidity and mortality. Contraceptive implants are a safe, effective, long term and reversible family planning method whose use remains low in Kenya. We therefore set out to determine and compare the uptake, and factors influencing uptake of immediate p...

متن کامل

Preparation of a reservoir type levonorgestrel delivery system using high molecular weight poly L-lactide

Implantable contraceptive is likely to be a promising new option for fertility control, as we have entered the twenty-first century and the world’s population grows by one billion people in a single decade. The main objective of this study was to develop a subdermal implant for levonorgestrol (a synthetic progestin from 19-norandrostanes) using a high molecular weight biodegradable polymer , i....

متن کامل

Preparation of a reservoir type levonorgestrel delivery system using high molecular weight poly L-lactide

Implantable contraceptive is likely to be a promising new option for fertility control, as we have entered the twenty-first century and the world’s population grows by one billion people in a single decade. The main objective of this study was to develop a subdermal implant for levonorgestrol (a synthetic progestin from 19-norandrostanes) using a high molecular weight biodegradable polymer , i....

متن کامل

Methods of accurate localisation of non-palpable subdermal contraceptive implants.

©FSRH J Fam Plann Reprod Health Care 2008: 34(1) Introduction Implanon® (Organon International, Oss, The Netherlands) is a single rod, subdermal contraceptive implant system designed to release the progestogen etonogestrel at a near constant rate over 3 years.1,2 This system entered the market in The Netherlands in 1998, and soon after in many other countries in Europe and Asia. It is now marke...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Contraception

دوره 84 4  شماره 

صفحات  -

تاریخ انتشار 2011